Tumorigenesis and Neoplastic Progression Yin Yang 1 Plays an Essential Role in Breast Cancer and Negatively Regulates p 27

From the Comprehensive Cancer Center Department of Cancer Biology,* and the Departments of Pathology, Biostatistical Sciences, and Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina; the College of Life Science, Shaanxi Key Laboratory for Molecule Biology of Agriculture, Northwest Agriculture and Forestry University, Yangling, China; and the Department of Medical Oncology, the Third Affiliated Hospital of Harbin Medical University, Harbin, China

[1]  L. Miller,et al.  Yin Yang 1 contains G-quadruplex structures in its promoter and 5′-UTR and its expression is modulated by G4 resolvase 1 , 2011, Nucleic acids research.

[2]  Yang Shi,et al.  Transcriptional repression by YY1, a human GLI-Krüippel-related protein, and relief of repression by adenovirus E1A protein , 1991, Cell.

[3]  E. Moran,et al.  Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. , 1995, Genes & development.

[4]  L. Khachigian,et al.  Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and p21WAF1/Cip1-Cdk4-Cyclin D1 Assembly , 2007, Circulation research.

[5]  R. Roberts Faculty Opinions recommendation of mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. , 2007 .

[6]  C. Deng,et al.  Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation , 2012, Oncogene.

[7]  Goberdhan P Dimri,et al.  Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. , 2007, Cancer research.

[8]  T. Kute,et al.  Measurement of Glut-1 Expression Using Tissue Microarrays to Determine a Race Specific Prognostic Marker for Breast Cancer , 2005, Breast Cancer Research and Treatment.

[9]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[10]  M. Whiteley,et al.  The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. , 1998, Molecular cell.

[11]  Kazushi Inoue,et al.  The oncogenic role of Yin Yang 1. , 2011, Critical reviews in oncogenesis.

[12]  T. Kute,et al.  Measurement of PTEN expression using tissue microarrays to determine a race-specific prognostic marker in breast cancer. , 2007, Archives of pathology & laboratory medicine.

[13]  Yosef Yarden,et al.  Molecular mechanisms underlying ErbB2/HER2 action in breast cancer , 2000, Oncogene.

[14]  T. Yeatman,et al.  Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. , 2008, Cancer research.

[15]  Yang Shi,et al.  Gene silencing by a DNA vector-based RNAi technology. , 2005, Methods in molecular biology.

[16]  Yudi Pawitan,et al.  Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients , 2006, Breast Cancer Research.

[17]  Michael T. McManus,et al.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference , 2003, Nature Genetics.

[18]  M. Olivé,et al.  Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.

[19]  Debashis Ghosh,et al.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Bonavida,et al.  Transcription factor YY1: structure, function, and therapeutic implications in cancer biology , 2006, Oncogene.

[21]  D. Spandidos,et al.  Yin Yang 1 expression in human tumors , 2010, Cell cycle.

[22]  P. Kang,et al.  Interaction between YY1 and the Retinoblastoma Protein , 2001, The Journal of Biological Chemistry.

[23]  S. Horvath,et al.  Expression of transcription factor Yin Yang 1 in prostate cancer. , 2005, International journal of oncology.

[24]  L. Kopelovich,et al.  The epigenome as a target for cancer chemoprevention. , 2003, Journal of the National Cancer Institute.

[25]  F. Lovat,et al.  p27kip1 Controls Cell Morphology and Motility by Regulating Microtubule-Dependent Lipid Raft Recycling , 2010, Molecular and Cellular Biology.

[26]  W. Hahn,et al.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.

[27]  Joanna R. Morris,et al.  BRCA1 methylation: a significant role in tumour development? , 2002, Seminars in cancer biology.

[28]  Jacques Boniver,et al.  The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors , 2008, Breast Cancer Research.

[29]  S. Weitzman,et al.  p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc , 2008, Oncogene.

[30]  Yi Zhang,et al.  Hierarchical recruitment of polycomb group silencing complexes. , 2004, Molecular cell.

[31]  S. Grossman,et al.  Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.

[32]  S. Bates,et al.  Characterization of estrogen responsive transforming activity in human breast cancer cell lines. , 1986, Cancer research.

[33]  S. Cramer,et al.  Yin Yang 1 Regulates the Transcriptional Activity of Androgen Receptor , 2009, Oncogene.

[34]  P. Hall,et al.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Seto,et al.  Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.

[36]  L. Hengst,et al.  p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 , 2007, Cell.

[37]  M. Tomayko,et al.  Determination of subcutaneous tumor size in athymic (nude) mice , 2004, Cancer Chemotherapy and Pharmacology.

[38]  Jeng-Shin Lee,et al.  Everything you have ever wanted to know about Yin Yang 1...... , 1997, Biochimica et biophysica acta.

[39]  Jeremy J. W. Chen,et al.  Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1. , 2007, Cancer research.

[40]  Jayanta Debnath,et al.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.

[41]  N. Bonini,et al.  Transcription factor YY1 functions as a PcG protein in vivo , 2003, The EMBO journal.

[42]  W. Forrester,et al.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Mina J. Bissell,et al.  Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets , 2008, PloS one.

[44]  T. Ekström,et al.  YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. , 2004, Biochemical and biophysical research communications.

[45]  D. A. Engel,et al.  Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB , 1995, Journal of virology.

[46]  S. Isom,et al.  The podosome marker protein Tks5 regulates macrophage invasive behavior , 2011, Cytoskeleton.

[47]  Andrew P Feinberg,et al.  An integrated epigenetic and genetic approach to common human disease. , 2004, Trends in genetics : TIG.

[48]  Pascale Jackers,et al.  Yin Yang 1 Cooperates with Activator Protein 2 to Stimulate ERBB2 Gene Expression in Mammary Cancer Cells* , 2005, Journal of Biological Chemistry.

[49]  Guangchao Sui,et al.  PIASy-Mediated Sumoylation of Yin Yang 1 Depends on Their Interaction but Not the RING Finger , 2007, Molecular and Cellular Biology.

[50]  Yu Pan,et al.  MDM2 Promotes Ubiquitination and Degradation of MDMX , 2003, Molecular and Cellular Biology.

[51]  C. Deng,et al.  BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution , 2006, Nucleic acids research.

[52]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[53]  Guangchao Sui,et al.  The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy , 2009 .

[54]  I. Ellis,et al.  Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification , 2009, Breast Cancer Research.

[55]  G. Lyons,et al.  The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. , 2004, Genes & development.

[56]  Giancarlo Castellano,et al.  The involvement of the transcription factor Yin Yang 1 in cancer development and progression , 2009, Cell cycle.

[57]  Hong Sun,et al.  p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27 , 1999, Current Biology.

[58]  A. Thompson,et al.  p53 mutation, deprivation and poor prognosis in primary breast cancer , 2010, British Journal of Cancer.

[59]  J. Slingerland,et al.  Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer , 2003, Breast Cancer Research.

[60]  Mina J Bissell,et al.  Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. , 2005, Seminars in cancer biology.

[61]  N. Normanno,et al.  Additive effects of c‐erbB‐2, c‐Ha‐ras, and transforming growth factor‐α genes on in vitro transformation of human mammary epithelial cells , 1992, Molecular carcinogenesis.

[62]  J. Sinclair,et al.  Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death. , 2005, European journal of cell biology.

[63]  Wen‐Ming Yang,et al.  Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Ericsson,et al.  YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Jianfeng Xu,et al.  Open Access RESEARCH , 2010 .